These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 12419242)

  • 21. Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action.
    Ebihara K; Ogawa Y; Katsuura G; Numata Y; Masuzaki H; Satoh N; Tamaki M; Yoshioka T; Hayase M; Matsuoka N; Aizawa-Abe M; Yoshimasa Y; Nakao K
    Diabetes; 1999 Oct; 48(10):2028-33. PubMed ID: 10512369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leptin signaling, adiposity, and energy balance.
    Jéquier E
    Ann N Y Acad Sci; 2002 Jun; 967():379-88. PubMed ID: 12079865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.
    Marsh DJ; Hollopeter G; Huszar D; Laufer R; Yagaloff KA; Fisher SL; Burn P; Palmiter RD
    Nat Genet; 1999 Jan; 21(1):119-22. PubMed ID: 9916804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intercommunication between bone and central nervous system].
    Takeda S
    Clin Calcium; 2013 Feb; 23(2):173-9. PubMed ID: 23354083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum leptin level is a regulator of bone mass.
    Elefteriou F; Takeda S; Ebihara K; Magre J; Patano N; Kim CA; Ogawa Y; Liu X; Ware SM; Craigen WJ; Robert JJ; Vinson C; Nakao K; Capeau J; Karsenty G
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3258-63. PubMed ID: 14978271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-related regulation of bone formation by the sympathetic cannabinoid CB1 receptor.
    Deis S; Srivastava RK; Ruiz de Azua I; Bindila L; Baraghithy S; Lutz B; Bab I; Tam J
    Bone; 2018 Mar; 108():34-42. PubMed ID: 29274505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiology: do neural signals remodel bone?
    Elmquist JK; Strewler GJ
    Nature; 2005 Mar; 434(7032):447-8. PubMed ID: 15791237
    [No Abstract]   [Full Text] [Related]  

  • 28. Monosodium glutamate-sensitive hypothalamic neurons contribute to the control of bone mass.
    Elefteriou F; Takeda S; Liu X; Armstrong D; Karsenty G
    Endocrinology; 2003 Sep; 144(9):3842-7. PubMed ID: 12933656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central proopiomelanocortin but not neuropeptide Y mediates sympathoexcitation and hypertension in fat fed conscious rabbits.
    Barzel B; Lim K; Davern PJ; Burke SL; Armitage JA; Head GA
    J Hypertens; 2016 Mar; 34(3):464-73; discussion 473. PubMed ID: 26820476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Leptin].
    Ikeda K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():82-4. PubMed ID: 15035101
    [No Abstract]   [Full Text] [Related]  

  • 31. The molecular clock mediates leptin-regulated bone formation.
    Fu L; Patel MS; Bradley A; Wagner EF; Karsenty G
    Cell; 2005 Sep; 122(5):803-15. PubMed ID: 16143109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual.
    Kajimura D; Hinoi E; Ferron M; Kode A; Riley KJ; Zhou B; Guo XE; Karsenty G
    J Exp Med; 2011 Apr; 208(4):841-51. PubMed ID: 21444660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoporosis: a neuroskeletal disease?
    Takeda S
    Int J Biochem Cell Biol; 2009 Mar; 41(3):455-9. PubMed ID: 18761104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species.
    Kondo H; Takeuchi S; Togari A
    Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E507-15. PubMed ID: 23169789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Energy Deficit in Mice Causes Long-Lasting Hypothalamic Alterations after Recovery.
    Méquinion M; Le Thuc O; Zgheib S; Alexandre D; Chartrel N; Rovère C; Hardouin P; Viltart O; Chauveau C
    Neuroendocrinology; 2017; 105(4):372-383. PubMed ID: 28006784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone remodeling: new aspects of a key process that controls skeletal maintenance and repair.
    Pogoda P; Priemel M; Rueger JM; Amling M
    Osteoporos Int; 2005 Mar; 16 Suppl 2():S18-24. PubMed ID: 15551056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Central control of bone metabolism].
    Takeda S
    Clin Calcium; 2005 May; 15(5):797-804. PubMed ID: 15876742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sympathetic neural influence on bone metabolism in microgravity (Review).
    Mano T; Nishimura N; Iwase S
    Acta Physiol Hung; 2010 Dec; 97(4):354-61. PubMed ID: 21138811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Hypothalamic VGF in Energy Balance and Metabolic Adaption to Environmental Enrichment in Mice.
    Foglesong GD; Huang W; Liu X; Slater AM; Siu J; Yildiz V; Salton SR; Cao L
    Endocrinology; 2016 Mar; 157(3):983-96. PubMed ID: 26730934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.
    Fonseca TL; Jorgetti V; Costa CC; Capelo LP; Covarrubias AE; Moulatlet AC; Teixeira MB; Hesse E; Morethson P; Beber EH; Freitas FR; Wang CC; Nonaka KO; Oliveira R; Casarini DE; Zorn TM; Brum PC; Gouveia CH
    J Bone Miner Res; 2011 Mar; 26(3):591-603. PubMed ID: 20814988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.